NACDS Urges Changes to Drug Reimbursements

The National Association of Chain Drug Stores, in a letter sent this week to three committee chairmen who endorse health care reform bill H.R. 3200, recommends changes to the average manufacturer price definition and AMP multiplier in calculating drug reimbursements for retail pharmacy.

ALEXANDRIA, Va. — The National Association of Chain Drug Stores, in a letter sent this week to three committee chairmen who endorse health care reform bill H.R. 3200, recommends changes to the average manufacturer price definition and AMP multiplier in calculating drug reimbursements for retail pharmacy.

Register to view the full article